Department of Medical BioSciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Department of Pediatric Nephrology, Olga Hospital, Clinics of Stuttgart, 70174 Stuttgart, Germany.
J Clin Endocrinol Metab. 2023 Aug 18;108(9):e754-e768. doi: 10.1210/clinem/dgad147.
Kenny-Caffey syndrome (KCS) is a rare hereditary disorder characterized by short stature, hypoparathyroidism, and electrolyte disturbances. KCS1 and KCS2 are caused by pathogenic variants in TBCE and FAM111A, respectively. Clinically the phenotypes are difficult to distinguish.
The objective was to determine and expand the phenotypic spectrum of KCS1 and KCS2 in order to anticipate complications that may arise in these disorders.
We clinically and genetically analyzed 10 KCS2 patients from 7 families. Because we found unusual phenotypes in our cohort, we performed a systematic review of genetically confirmed KCS cases using PubMed and Scopus. Evaluation by 3 researchers led to the inclusion of 26 papers for KCS1 and 16 for KCS2, totaling 205 patients. Data were extracted following the Cochrane guidelines and assessed by 2 independent researchers.
Several patients in our KCS2 cohort presented with intellectual disability (3/10) and chronic kidney disease (6/10), which are not considered common findings in KCS2. Systematic review of all reported KCS cases showed that the phenotypes of KCS1 and KCS2 overlap for postnatal growth retardation (KCS1: 52/52, KCS2: 23/23), low parathyroid hormone levels (121/121, 16/20), electrolyte disturbances (139/139, 24/27), dental abnormalities (47/50, 15/16), ocular abnormalities (57/60, 22/23), and seizures/spasms (103/115, 13/16). Symptoms more prevalent in KCS1 included intellectual disability (74/80, 5/24), whereas in KCS2 bone cortical thickening (1/18, 16/20) and medullary stenosis (7/46, 27/28) were more common.
Our case series established chronic kidney disease as a new feature of KCS2. In the literature, we found substantial overlap in the phenotypic spectra of KCS1 and KCS2, but identified intellectual disability and the abnormal bone phenotype as the most distinguishing features.
肯尼-卡菲综合征(KCS)是一种罕见的遗传性疾病,其特征为身材矮小、甲状旁腺功能减退和电解质紊乱。KCS1 和 KCS2 分别由 TBCE 和 FAM111A 中的致病性变异引起。临床上,这些表型难以区分。
确定和扩展 KCS1 和 KCS2 的表型谱,以便预测这些疾病可能出现的并发症。
我们对来自 7 个家庭的 10 名 KCS2 患者进行了临床和基因分析。由于我们在队列中发现了不寻常的表型,因此我们使用 PubMed 和 Scopus 对已确认遗传的 KCS 病例进行了系统综述。由 3 名研究人员进行评估,共纳入 26 篇关于 KCS1 的论文和 16 篇关于 KCS2 的论文,共 205 名患者。按照 Cochrane 指南提取数据,并由 2 名独立研究人员进行评估。
我们 KCS2 队列中的一些患者表现出智力障碍(3/10)和慢性肾脏病(6/10),这在 KCS2 中并不常见。对所有报告的 KCS 病例的系统综述表明,KCS1 和 KCS2 的表型在出生后生长迟缓(KCS1:52/52,KCS2:23/23)、甲状旁腺激素水平低(121/121,16/20)、电解质紊乱(139/139,24/27)、牙齿异常(47/50,15/16)、眼部异常(57/60,22/23)和癫痫发作/痉挛(103/115,13/16)方面存在重叠。在 KCS1 中更常见的症状包括智力障碍(74/80,5/24),而在 KCS2 中更常见的是骨皮质增厚(1/18,16/20)和骨髓狭窄(7/46,27/28)。
我们的病例系列确立了慢性肾脏病是 KCS2 的一个新特征。在文献中,我们发现 KCS1 和 KCS2 的表型谱存在很大的重叠,但发现智力障碍和异常骨骼表型是最具鉴别特征的特征。